|
Name |
3-Hydroxy-4-(4-hydroxyphenyl)-5-methoxycarbonyl-5-(4-hydroxy-3-formylbenzyl)-2,5-dihydro-2-furanone
|
Molecular Formula | C20H16O8 | |
IUPAC Name* |
methyl (2R)-2-[(3-formyl-4-hydroxyphenyl)methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
|
|
SMILES |
COC(=O)[C@]1(C(=C(C(=O)O1)O)C2=CC=C(C=C2)O)CC3=CC(=C(C=C3)O)C=O
|
|
InChI |
InChI=1S/C20H16O8/c1-27-19(26)20(9-11-2-7-15(23)13(8-11)10-21)16(17(24)18(25)28-20)12-3-5-14(22)6-4-12/h2-8,10,22-24H,9H2,1H3/t20-/m1/s1
|
|
InChIKey |
XRPSJKOYIJOFHY-HXUWFJFHSA-N
|
|
Synonyms |
CHEMBL4643065; 3-hydroxy-4-(4-hydroxyphenyl)-5-methoxycarbonyl-5-(4-hydroxy-3-formylbenzyl)-2,5-dihydro-2-furanone
|
|
CAS | NA | |
PubChem CID | 139587026 | |
ChEMBL ID | CHEMBL4643065 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 384.3 | ALogp: | 2.5 |
HBD: | 3 | HBA: | 8 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 130.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 28 | QED Weighted: | 0.529 |
Caco-2 Permeability: | -5.052 | MDCK Permeability: | 0.00000890 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.059 | 20% Bioavailability (F20%): | 0.788 |
30% Bioavailability (F30%): | 0.951 |
Blood-Brain-Barrier Penetration (BBB): | 0.026 | Plasma Protein Binding (PPB): | 94.22% |
Volume Distribution (VD): | 0.335 | Fu: | 3.85% |
CYP1A2-inhibitor: | 0.134 | CYP1A2-substrate: | 0.467 |
CYP2C19-inhibitor: | 0.803 | CYP2C19-substrate: | 0.066 |
CYP2C9-inhibitor: | 0.856 | CYP2C9-substrate: | 0.917 |
CYP2D6-inhibitor: | 0.186 | CYP2D6-substrate: | 0.373 |
CYP3A4-inhibitor: | 0.799 | CYP3A4-substrate: | 0.272 |
Clearance (CL): | 9.811 | Half-life (T1/2): | 0.596 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.14 |
Drug-inuced Liver Injury (DILI): | 0.383 | AMES Toxicity: | 0.134 |
Rat Oral Acute Toxicity: | 0.108 | Maximum Recommended Daily Dose: | 0.061 |
Skin Sensitization: | 0.107 | Carcinogencity: | 0.173 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.248 |
Respiratory Toxicity: | 0.043 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000875 | 0.742 | D0J7RK | 0.337 | ||||
ENC002729 | 0.742 | D06KYN | 0.315 | ||||
ENC002571 | 0.733 | D06TJJ | 0.307 | ||||
ENC002376 | 0.708 | D04AIT | 0.298 | ||||
ENC002552 | 0.708 | D0Q9ON | 0.291 | ||||
ENC002705 | 0.694 | D04XEG | 0.290 | ||||
ENC002711 | 0.694 | D04KJO | 0.289 | ||||
ENC002900 | 0.650 | D0Q1IT | 0.289 | ||||
ENC002561 | 0.646 | D0D1DI | 0.289 | ||||
ENC003113 | 0.618 | D00LFB | 0.283 |